Tuesday, May 16 2023
01:55 PM – 02:20 PM PT
Value Demonstration and Access Considerations for Gene Therapies
Clark Paramore, MSPH. Bluebird bio, MA
Disclosures: C. Paramore: 1; Commercial Interest i.e. Company X; Bluebird bio. 1; What was received? i.e. Honorarium; Stock. 1; For what role? i.e. Speaker; Employee.